Ichiro Yamauchi

660 total citations
34 papers, 442 citations indexed

About

Ichiro Yamauchi is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology. According to data from OpenAlex, Ichiro Yamauchi has authored 34 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Ichiro Yamauchi's work include Thyroid Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Ichiro Yamauchi is often cited by papers focused on Thyroid Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Ichiro Yamauchi collaborates with scholars based in Japan, Australia and Singapore. Ichiro Yamauchi's co-authors include Nobuya Inagaki, Toshihito Fujii, Akihiro Yasoda, Yohei Ueda, Keisho Hirota, Daisuke Taura, Yugo Kanai, Masakatsu Sone, Eri Kondo and Yui Yamashita and has published in prestigious journals such as Journal of Clinical Investigation, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Ichiro Yamauchi

26 papers receiving 439 citations

Peers

Countries citing papers authored by Ichiro Yamauchi

Since Specialization

Citations

This map shows the geographic impact of Ichiro Yamauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Yamauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Yamauchi more than expected).

Fields of papers citing papers by Ichiro Yamauchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Yamauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Yamauchi. The network helps show where Ichiro Yamauchi may publish in the future.

Co-authorship network of co-authors of Ichiro Yamauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Yamauchi. A scholar is included among the top collaborators of Ichiro Yamauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Yamauchi. Ichiro Yamauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Significance of High Expression of Circulating miR-222-3p in Patients With Unilateral Primary Aldosteronism 2025 ·The Journal of Clinical Endocrinology & Metabolism ·Kentaro Okamoto, Masakatsu Sone, Daisuke Taura, Youichi Ohno, Ichiro Yamauchi, Yohei Ueda, (unknown), Mika Tsuiki, Masanori Murakami, Daisuke Yabe, Nobuya Inagaki, Mitsuhide Naruse	0
2	Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70<sup>TM</sup> in Japanese Graves’ disease patients: results of a phase 1 trial 2025 ·Endocrine Journal ·Jaeduk Yoshimura Noh, Natsuko Watanabe, Kohichi Ito, Mika Tsuiki, Yuki Ishihara, Tetsuya Tagami, Ichiro Yamauchi, (unknown), (unknown), Bernard Rees Smith	0
3	Tumor-Induced Osteomalacia Localized by Systemic Venous Sampling and 68Ga-DOTATOC Positron Emission Tomography 2025 ·JCEM Case Reports ·Tomomi Nakao, Ken Takeshima, Shuhei Morita, Ichiro Yamauchi, Sho Koyasu, Taka‐aki Matsuoka	0
4	Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors 2025 ·European Thyroid Journal ·Ichiro Yamauchi, Daisuke Yabe	5
5	Growth hormone regulates deiodinase type 2 and 3 expression via GATA 2025 ·Growth Hormone & IGF Research ·(unknown), (unknown), (unknown), (unknown), Misa Hayashi, Ichiro Yamauchi, Tetsuya Tagami, Kenji Moriyama	0
6	Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway 2024 ·Endocrinology ·(unknown), Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, (unknown), (unknown), (unknown), Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki	4
7	High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation 2024 ·Endocrinology ·(unknown), Ichiro Yamauchi, (unknown), (unknown), (unknown), Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki	0
8	TRIAC disrupts cerebral thyroid hormone action via negative feedback and heterogenous distribution among organs 2023 ·iScience ·Ichiro Yamauchi, (unknown), Yohei Ueda, (unknown), (unknown), (unknown), Shoji F. Nakayama, Daisuke Nakajima, Takuya Kubo, Nobuya Inagaki	2
9	18F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma 2023 ·Frontiers in Endocrinology ·(unknown), Takaaki Murakami, Hiroyuki Fujimoto, Yoichi Shimizu, Kanae K. Miyake, (unknown), (unknown), Takuya Okada, Masakazu Fujimoto, (unknown), Ichiro Yamauchi, Kotaro Shimada, (unknown), Kazuyuki Nagai, Yuji Nakamoto, Nobuya Inagaki	5
10	High-throughput Screening in Combination With a Cohort Study for Iodothyronine Deiodinases 2022 ·Endocrinology ·Ichiro Yamauchi, (unknown), Yukiko Okuno, (unknown), (unknown), (unknown), Kentaro Okamoto, Daisuke Taura, Takafumi Yamashita, Keisho Hirota, Yohei Ueda, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki	5
11	C-type natriuretic peptide facilitates autonomic Ca²⁺ entry in growth plate chondrocytes for stimulating bone growth 2022 ·Kyoto University Research Information Repository (Kyoto University) ·(unknown), Atsuhiko Ichimura, (unknown), Naoki Okamoto, (unknown), Feng Liu, (unknown), (unknown), Yohei Ueda, Ichiro Yamauchi, (unknown), Kazumasa Nakao, Sho Kakizawa, Miyuki Nishi, Yasuo Mori, Haruhiko Akiyama, Kazuwa Nakao, Hiroshi Takeshima	15
12	Identification by Liquid Chromatography–Tandem Mass Spectrometry and Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry of the Contributor to the Thyroid Hormone Receptor Agonist Activity in Effluents from Sewage Treatment Plants 2022 ·Environmental Science & Technology ·(unknown), (unknown), Fujio Shiraishi, Shoji F. Nakayama, Masanori Terasaki, Tetsuya Tanigawa, Ichiro Yamauchi, Takuya Kubo, Daisuke Nakajima	2
13	Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo 2022 ·PLoS ONE ·(unknown), Kazumasa Nakao, (unknown), Ichiro Yamauchi, Takafumi Yamashita, Toshihito Fujii, Yohei Ueda, Mariko Kawai, Takuma Watanabe, Shizuko Fukuhara, Kazuhisa Bessho	2
14	Effect of C-type natriuretic peptide on craniofacial skeletogenesis in mice during the pubertal growth spurt 2022 ·Archives of Oral Biology ·(unknown), Kazumasa Nakao, (unknown), Ichiro Yamauchi, Takafumi Yamashita, Toshihito Fujii, Yohei Ueda, Mariko Kawai, Takuma Watanabe, Shizuko Fukuhara, Kazuhisa Bessho	0
15	Bezafibrate induces hypothyroidism in a patient with resistance to thyroid hormone β due to a G347R variant 2021 ·Clinical Endocrinology ·Ichiro Yamauchi, Takafumi Yamashita, (unknown), Tetsuya Tagami, Ikuko Hanaoka, Takeshi Usui, Keisho Hirota, (unknown), Yohei Ueda, Toshihito Fujii, (unknown), Akihiro Yasoda, Nobuya Inagaki	2
16	Clinical features and thyroid dysfunction in adverse events involving the pituitary gland during PD‐1 blockade therapy 2020 ·Clinical Endocrinology ·Ichiro Yamauchi, Daisuke Taura, (unknown), (unknown), Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Nobuya Inagaki	13
17	Is C-type natriuretic peptide regulated by a feedback loop? A study on systemic and local autoregulatory effect 2020 ·PLoS ONE ·Yohei Ueda, Keisho Hirota, Ichiro Yamauchi, (unknown), Takafumi Yamashita, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki	6
18	Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab 2019 ·PLoS ONE ·Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Heike, Masakatsu Hishizawa, Nobuko Kawaguchi‐Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki	105
19	Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study 2017 ·Thyroid ·Ichiro Yamauchi, (unknown), (unknown), Toshihito Fujii, Daisuke Taura, Masakazu Hirata, Keisho Hirota, Yohei Ueda, Yugo Kanai, Yui Yamashita, Eri Kondo, Masakatsu Sone, Akihiro Yasoda, Nobuya Inagaki	118
20	Regulation of type 1 iodothyronine deiodinase by LXRα 2017 ·PLoS ONE ·(unknown), Naotetsu Kanamoto, Ichiro Yamauchi, Tetsuya Tagami, Yusuke Morita, Masako Miura, Masakatsu Sone, Akihiro Yasoda, Takeshi Kimura, Kazuwa Nakao, Nobuya Inagaki	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact